Edgewise Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
If everyone can take their seats. I'm very (multiple speakers) okay, should be on. Perfect. Well, good morning, everyone. My name is Jason Zemansky and the new SMid-Cap Biotech Analyst here at BofA. and I'm very pleased this morning to be able to introduce Kevin Koch at Edgewise. Good morning.
Hi! How are you doing?
Questions & Answers
Perfect. Well, maybe to start more broadly, can you remind us your lead program 5506? How does it work? And how does it impact muscle damage?
Yes. So (technical difficulty) a little bit lower. Okay, so how it affects muscle damage? So during in Duchenne and Becker muscular dystrophy, they're missing a key structural protein called
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
